Latest California Healthline Stories
Watch: The Nitty-Gritty of Medicare Drug Price Negotiations — And Patients’ Potential Savings
KHN chief Washington correspondent Julie Rovner discusses the Senate Democrats’ plans to let Medicare negotiate some drug prices, cap out-of-pocket drug costs for seniors, and fund enhanced subsides for ACA marketplace health plans.
Nursing Homes Are Suing the Friends and Family of Residents to Collect Debts
Debt lawsuits — long a byproduct of America’s medical debt crisis — can ensnare not only patients but also those who help sick and older people be admitted to nursing homes, a KHN-NPR investigation finds.
Health Insurance Price Data: It’s Out There, but It’s Not for the Faint of Heart
Health insurers and self-insured employer plans are now required to post their negotiated rates for almost every type of medical service. But navigating through the trove of information is no easy task.
The Ambulance Chased One Patient Into Collections
After a car wreck, three siblings were transported to the same hospital by ambulances from three separate districts. The sibling with the most minor injuries got the biggest bill.
Listen: Can California Lower the Price of Insulin?
California Healthline senior correspondent Angela Hart describes California’s ambitious plan to manufacture generic insulin under the state’s new “CalRx” drug label.
‘True Cost of Aging’ Index Shows Many Seniors Can’t Afford Basic Necessities
The Elder Index, developed by researchers at the University of Massachusetts-Boston, shows that nearly 5 million older women living alone, 2 million older men living alone, and more than 2 million older couples have incomes that make them economically insecure.
‘So Rudderless’: A Couple’s Quest for Autism Treatment for Their Son Hits Repeated Obstacles
Amparo and Victor Rios began searching for answers about their son’s development when he didn’t hit some milestones after turning 2. Three years later, they are still trying to get their insurance to pay for expensive therapy to help him.
Parents Become Drug Developers to Save Their Children’s Lives
Families affected by ultra-rare diseases are starting their own companies to speed the development of treatments for their kids, venturing into territory that traditional drugmakers deem too risky.
A Free-for-All From Readers and Tweeters, From Medical Debt to Homelessness
KHN gives readers a chance to comment on a recent batch of stories.
Listen: Why Medical Debt Touches Every Corner of America
KHN senior correspondent Noam N. Levey joined WBEZ and Wisconsin Public Radio to talk about medical debt and health care costs in the U.S.